Prospective Analysis of Oncogenic Driver Mutations and Environmental Factors: Japan Molecular Epidemiology for Lung Cancer Study.
暂无分享,去创建一个
Shigeki Shimizu | Masahiko Ando | Norimasa Ito | Seiichi Kakegawa | Naoki Yoshimoto | Akihito Kubo | Tomoya Kawaguchi | Sadanori Takeo | Hideo Saka | Y. Ichinose | H. Saka | M. Ando | A. Kubo | Y. Koh | M. Serizawa | S. Shimizu | T. Tagawa | Yukito Ichinose | Yasuhiro Koh | Masakuni Serizawa | T. Kawaguchi | M. Yamashita | A. Tamiya | S. Takeo | Motohiro Yamashita | H. Adachi | Tsutomu Tagawa | Akihiro Tamiya | Hirofumi Adachi | Kazuhiko Kataoka | Yukiyasu Takeuchi | Akihide Matsumura | Shun-Ichi Isa | Y. Takeuchi | A. Matsumura | N. Ito | S. Isa | S. Kakegawa | K. Kataoka | N. Yoshimoto
[1] William Pao,et al. Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs. , 2014, JAMA.
[2] Leah E. Mechanic,et al. EGFR Somatic Mutations in Lung Tumors: Radon Exposure and Passive Smoking in Former- and Never-Smoking U.S. Women , 2012, Cancer Epidemiology, Biomarkers & Prevention.
[3] K. Bhaskaran,et al. Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5·24 million UK adults , 2014, The Lancet.
[4] A. Gazdar,et al. Lung cancer in never smokers — a different disease , 2007, Nature Reviews Cancer.
[5] Kenji Suzuki,et al. A Rational Diagnostic Algorithm for the Identification of ALK Rearrangement in Lung Cancer: A Comprehensive Study of Surgically Treated Japanese Patients , 2013, PloS one.
[6] T. Oyama,et al. Association between estrogen receptor-beta expression and epidermal growth factor receptor mutation in the postoperative prognosis of adenocarcinoma of the lung. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] J. Kaprio,et al. Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland. , 2000, The New England journal of medicine.
[8] R. Saito,et al. Performance Status and Smoking Status Are Independent Favorable Prognostic Factors for Survival in Non-small Cell Lung Cancer: A Comprehensive Analysis of 26,957 Patients with NSCLC , 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[9] Takeo Iwama,et al. Higher frequency of Smad4 gene mutation in human colorectal cancer with distant metastasis , 1999, Oncogene.
[10] P. Schlag,et al. Enhanced Detection and Typing of Human Papillomavirus (HPV) DNA in Anogenital Samples with PGMY Primers and the Linear Array HPV Genotyping Test , 2006, Journal of Clinical Microbiology.
[11] Ronglai Shen,et al. Molecular Epidemiology of EGFR and KRAS Mutations in 3,026 Lung Adenocarcinomas: Higher Susceptibility of Women to Smoking-Related KRAS-Mutant Cancers , 2012, Clinical Cancer Research.
[12] S. Ou,et al. Human papilloma virus in non-small cell lung cancer in never smokers: a systematic review of the literature. , 2014, Lung cancer.
[13] S. Peters,et al. BRAF Alterations as Therapeutic Targets in Non–Small-Cell Lung Cancer , 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[14] Steven J. M. Jones,et al. Comprehensive genomic characterization of squamous cell lung cancers , 2012, Nature.
[15] H. Saka,et al. Rationale and design of the Japan molecular epidemiology for lung cancer study. , 2013, Clinical lung cancer.
[16] S. Wacholder,et al. Assessment of Human Papillomavirus in Lung Tumor Tissue , 2011, Journal of the National Cancer Institute.
[17] H. Sasaki,et al. Long Exposure of Environmental Tobacco Smoke Associated with Activating EGFR Mutations in Never-Smokers with Non–Small Cell Lung Cancer , 2010, Clinical Cancer Research.
[18] Z. Szallasi,et al. Spatial and temporal diversity in genomic instability processes defines lung cancer evolution , 2014, Science.
[19] Li Ding,et al. Genomic Landscape of Non-Small Cell Lung Cancer in Smokers and Never-Smokers , 2012, Cell.
[20] H. Sasaki,et al. Overexpression of GLUT1 correlates with Kras mutations in lung carcinomas. , 2011, Molecular medicine reports.
[21] L. Diaz,et al. Liquid biopsies: genotyping circulating tumor DNA. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] B. Qian,et al. Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia , 2012, Nature Genetics.
[23] I. Wistuba,et al. Immunohistochemical Expression of Estrogen and Progesterone Receptors Identifies a Subset of NSCLCs and Correlates with EGFR Mutation , 2009, Clinical Cancer Research.
[24] Yong Soo Choi,et al. Integrative and comparative genomic analysis of lung squamous cell carcinomas in East Asian patients. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[25] S. Jee,et al. Impact of environmental tobacco smoke on the incidence of mutations in epidermal growth factor receptor gene in never-smoker patients with non-small-cell lung cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[26] H. Sasaki,et al. Genotype analysis of the NRF2 gene mutation in lung cancer. , 2013, International journal of molecular medicine.
[27] A. Jemal,et al. Cancer Statistics, 2010 , 2010, CA: a cancer journal for clinicians.
[28] Angela N. Brooks,et al. Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing , 2012, Cell.